NCT03777722View on ClinicalTrials.gov

Light and the Effect on Metabolic Syndrome and Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Alzheimer DiseaseDiabetes Mellitus, Type 2
Interventions
DEVICE

Tailored Lighting Intervention

Lighting Intervention - active or placebo

Trial Locations (3)

10029

Icahn School of Medicine, New York

12204

Icahn School of Medicine at Mount Sinai, Albany

08854

Rutgers University, New Brunswick

All Listed Sponsors
collaborator

Rutgers University

OTHER

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03777722 - Light and the Effect on Metabolic Syndrome and Alzheimer's Disease | Biotech Hunter | Biotech Hunter